217 related articles for article (PubMed ID: 35452896)
21. Congenital spindle cell rhabdomyosarcoma.
Whittle SB; Hicks MJ; Roy A; Vasudevan SA; Reddy K; Venkatramani R
Pediatr Blood Cancer; 2019 Nov; 66(11):e27935. PubMed ID: 31339226
[TBL] [Abstract][Full Text] [Related]
22. Beyond "Triton": Malignant Peripheral Nerve Sheath Tumors With Complete Heterologous Rhabdomyoblastic Differentiation Mimicking Spindle Cell Rhabdomyosarcoma.
Hornick JL; Nielsen GP
Am J Surg Pathol; 2019 Oct; 43(10):1323-1330. PubMed ID: 31107719
[TBL] [Abstract][Full Text] [Related]
23. Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases.
Mentzel T; Kuhnen C
Virchows Arch; 2006 Nov; 449(5):554-60. PubMed ID: 17013628
[TBL] [Abstract][Full Text] [Related]
24. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma.
Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F
Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044
[TBL] [Abstract][Full Text] [Related]
25. Spindle cell rhabdomyosarcoma in adults.
Nascimento AF; Fletcher CD
Am J Surg Pathol; 2005 Aug; 29(8):1106-13. PubMed ID: 16006807
[TBL] [Abstract][Full Text] [Related]
26. Localised rhabdomyosarcoma in infants (<12 months) and young children (12-36 months of age) treated on the EpSSG RMS 2005 study.
Slater O; Gains JE; Kelsey AM; De Corti F; Zanetti I; Coppadoro B; Jorgensen M; Gallego S; Orbach DH; Glosli H; Cesen M; Gaze MN; Smeulders N; Ferrari A; Jenney M; Minard-Colin V; Bisogno G; Merks JHM;
Eur J Cancer; 2022 Jan; 160():206-214. PubMed ID: 34865946
[TBL] [Abstract][Full Text] [Related]
27. Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease: A Study of 4 Aggressive Cases With Clinical, Pathologic, Molecular, and Radiologic Findings.
Cyrta J; Gauthier A; Karanian M; Vieira AF; Cardoen L; Jehanno N; Bouvet M; Bouvier C; Komuta M; Le Loarer F; Orbach D; Rome A; Minard-Colin V; Brichard B; Pluchart C; Thebaud E; Renard M; Pannier S; Brisse H; Petit P; Benoist C; Schleiermacher G; Geoerger B; Vincent-Salomon A; Fréneaux P; Pierron G
Am J Surg Pathol; 2021 Jun; 45(6):854-867. PubMed ID: 33949344
[TBL] [Abstract][Full Text] [Related]
28. Histopathological, immunohistochemical and molecular cytogenetic analysis of 21 spindle cell/sclerosing rhabdomyosarcomas.
Rekhi B; Singhvi T
APMIS; 2014 Nov; 122(11):1144-52. PubMed ID: 24730567
[TBL] [Abstract][Full Text] [Related]
29. Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR.
Heinz AT; Schönstein A; Ebinger M; Fuchs J; Timmermann B; Seitz G; Vokuhl C; Münter M; Pajtler KW; Stegmaier S; von Kalle T; Kratz CP; Ljungman G; Juntti H; Klingebiel T; Koscielniak E; Sparber-Sauer M;
Pediatr Blood Cancer; 2024 Jan; 71(1):e30707. PubMed ID: 37814424
[TBL] [Abstract][Full Text] [Related]
30. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
Yu L; Wang J
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377
[TBL] [Abstract][Full Text] [Related]
31. Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups.
Minard-Colin V; Walterhouse D; Bisogno G; Martelli H; Anderson J; Rodeberg DA; Ferrari A; Jenney M; Wolden S; De Salvo G; Arndt C; Merks JHM; Gallego S; Schwob D; Haie-Meder C; Bergeron C; Stevens MCG; Oberlin O; Hawkins D;
Pediatr Blood Cancer; 2018 Sep; 65(9):e27096. PubMed ID: 29781567
[TBL] [Abstract][Full Text] [Related]
32. Recurrent VGLL3 fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck.
Agaimy A; Dermawan JK; Leong I; Stoehr R; Swanson D; Weinreb I; Zhang L; Antonescu CR; Dickson BC
Genes Chromosomes Cancer; 2022 Dec; 61(12):701-709. PubMed ID: 35766997
[TBL] [Abstract][Full Text] [Related]
33. Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.
Rekhi B; Dodd L; Dharavath B; Dutt A
Diagn Cytopathol; 2022 Dec; 50(12):E367-E372. PubMed ID: 35929754
[TBL] [Abstract][Full Text] [Related]
34. Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with
Colletti M; Galardi A; Miele E; Di Paolo V; Russo I; De Stefanis C; De Vito R; Rinelli M; Ciolfi A; De Angelis B; Zin A; Guffanti A; Digilio MC; Novelli A; Alaggio R; Milano GM; Di Giannatale A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34067464
[No Abstract] [Full Text] [Related]
35. Local Resection and Brachytherapy for Primary Orbital Rhabdomyosarcoma: Outcome and Failure Pattern Analysis.
Schoot RA; Saeed P; Freling NJ; Blank LE; Pieters BR; van der Grient JN; Strackee SD; Bras J; Caron HN; Merks JH;
Ophthalmic Plast Reconstr Surg; 2016; 32(5):354-60. PubMed ID: 26398242
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment.
Liu YT; Wang CW; Hong RL; Kuo SH
Anticancer Res; 2019 Mar; 39(3):1355-1364. PubMed ID: 30842169
[TBL] [Abstract][Full Text] [Related]
37. Metastatic rhabdomyosarcoma with exclusive distant lymph node involvement: A European Pediatric Soft tissue sarcoma Study Group (EpSSG) report.
Mercolini F; Merks JHM; Minard-Colin V; Cameron A; van Scheltinga SEJT; Sher O; Fichera G; Orbach D; Glosli H; Coppadoro B; Gallego S; Chisholm JC; Bisogno G
Pediatr Blood Cancer; 2023 Mar; 70(3):e30143. PubMed ID: 36519598
[TBL] [Abstract][Full Text] [Related]
38. Local therapy is critical in localised pelvic rhabdomyosarcoma: experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee.
Réguerre Y; Martelli H; Rey A; Rogers T; Gaze M; Ben Arush MW; Devalck C; Oberlin O; Stevens M; Orbach D
Eur J Cancer; 2012 Sep; 48(13):2020-7. PubMed ID: 22154650
[TBL] [Abstract][Full Text] [Related]
39. Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee.
Rodeberg DA; Anderson JR; Arndt CA; Ferrer FA; Raney RB; Jenney ME; Brecht IB; Koscielniak E; Carli M; Bisogno G; Oberlin O; Rey A; Ullrich F; Stevens MC; Meyer WH
Int J Cancer; 2011 Mar; 128(5):1232-9. PubMed ID: 20473932
[TBL] [Abstract][Full Text] [Related]
40. Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region. A report of the Intergroup Rhabdomyosarcoma Study.
Leuschner I; Newton WA; Schmidt D; Sachs N; Asmar L; Hamoudi A; Harms D; Maurer HM
Am J Surg Pathol; 1993 Mar; 17(3):221-30. PubMed ID: 8434703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]